Results 301 to 310 of about 185,125 (388)

Sex-specific Association of Chronic Proton Pump Inhibitor Use With Reduced Bone Density and Quality.

J Clin Endocrinol Metab
Bioletto F, Pusterla A, Fraire F, Sauro L, Presti M, Arvat E, Ghigo E, Procopio M, Barale M.   +8 more
europepmc   +1 more source

Trends in Proton Pump Inhibitor Use in Sweden by Sex and Age: A Drug Utilisation Study. [PDF]

Drug Saf
Brusselaers N, Gudnadottir U, Engstrand L, Lilja HE.   +3 more
europepmc   +1 more source

Perovskite Quantum Dots: Fabrication, Degradation, and Enhanced Performance Across Solar Cells, Optoelectronics, and Quantum Technologies

Carbon Energy, EarlyView.
Metal halide perovskite quantum dots (PQDs) have been extensively explored due to their unique optical/optoelectronic properties such as tunable wavelength, narrow emission, and high photoluminescence quantum efficiency. This critical review article is an overview of the fabrication methods, degradation mechanisms of PQDs and explores strategies for ...
Sikandar Aftab, Zeeshan Ali, M. Imtiaz Hussain, Mohammed A. Assiri, Najaf Rubab, Faruk Ozel, Erdi Akman   +6 more
wiley   +1 more source

Irrational proton pump inhibitor use during corticosteroid therapy

The Egyptian Journal of Internal Medicine, 2018
Rakesh Agarwal, Rashmi Baid
doaj   +1 more source

Dementia, cognitive impairment and proton pump inhibitor therapy: A systematic review

Journal of Gastroenterology and Hepatology, 2017
R. Batchelor, Julia Fiona-Maree Gilmartin, W. Kemp, I. Hopper, D. Liew   +4 more
semanticscholar   +1 more source

Association of Proton Pump Inhibitor Use With Gastric Cancer in Regions With High Prevalence of Gastric Cancer: Systematic Review and Meta-analysis. [PDF]

J Neurogastroenterol Motil
Kang SJ, Lee KJ.
europepmc   +1 more source

Novel Para‐Phenylenediamine‐Based Derivatives as Receptor Tyrosine Kinase‐like Orphan Receptor 1 (ROR1) Inhibitors: An In Vitro Preliminary Characterization

ChemMedChem, EarlyView.
ROR1 represents a promising target for the development of novel antiproliferative compounds, giving its high expression in different cancer cell lines. The present study describes the workflow leading to the design, synthesis, and characterization of a series of para‐phenylenediamine‐based compounds able to interact with the target kinase, inhibiting ...
Gerardina Smaldone, Maria Rosaria Miranda, Francesca Di Matteo, Valeria Napolitano, Michela Aliberti, Simona Musella, Veronica Di Sarno, Gianluigi Lauro, Giuseppe Bifulco, Giacomo Pepe, Giovanna Aquino, Mario Felice Tecce, Isabel Maria Gomez‐Monterrey, Pietro Campiglia, Carmine Ostacolo, Alessia Bertamino, Vincenzo Vestuto, Tania Ciaglia   +17 more
wiley   +1 more source

The impact of proton pump inhibitor therapy on patients with liver disease

Alimentary Pharmacology and Therapeutics, 2016
H. Cole, S. Pennycook, P. Hayes
semanticscholar   +1 more source

Proton Pump Inhibitor Use and Its Association with Lung Cancer Likelihood and Mortality: A Nationwide Nested Case-Control Study in Korea. [PDF]

Cancers (Basel)
Kwon MJ, Kang HS, Choi HG, Kim JH, Kim JH, Bang WJ, Yoo DM, Lee NE, Han KM, Kim NY, Hong S, Lee HK.   +11 more
europepmc   +1 more source

Identification of a New Interesting BAG3 Modulator Able to Disrupt Cancer‐Related Pathways

ChemMedChem, Accepted Article.
Continuing our research aimed at discovering new BAG3 modulators as attractive anticancer drug candidates, we performed a screening campaign on an in‐house library, including compounds featuring a large variety of scaffolds. The obtained results induced us to focus on the triazole moiety and, following a stepwise structural refinement of the scaffold ...
Dafne Ruggiero, Eleonora Boccia, Emis Ingenito, Vincenzo Vestuto, Gilda D’Urso, Alessandra Capuano, Agostino Casapullo, Stefania Terracciano, Giuseppe Bifulco, Gianluigi Lauro, Ines Bruno   +10 more
wiley   +1 more source